These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 18440692
41. Antiangiogenic and proapoptotic activities of allyl isothiocyanate inhibit ascites tumor growth in vivo. Kumar A, D'Souza SS, Tickoo S, Salimath BP, Singh HB. Integr Cancer Ther; 2009 Mar; 8(1):75-87. PubMed ID: 19223371 [Abstract] [Full Text] [Related]
42. Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK/mTOR signaling pathway. Lee JS, Sul JY, Park JB, Lee MS, Cha EY, Ko YB. Int J Mol Med; 2019 May; 43(5):1969-1978. PubMed ID: 30864681 [Abstract] [Full Text] [Related]
43. Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma. Kim W, Yoon JH, Kim JR, Jang IJ, Bang YJ, Kim YJ, Lee HS. Cancer Chemother Pharmacol; 2009 Aug; 64(3):497-507. PubMed ID: 19096848 [Abstract] [Full Text] [Related]
44. Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer. Luo H, Zhong Q, Chen LJ, Qi XR, Fu AF, Yang HS, Yang F, Lin HG, Wei YQ, Zhao X. J Cancer Res Clin Oncol; 2008 Sep; 134(9):937-45. PubMed ID: 18350317 [Abstract] [Full Text] [Related]
45. EPOX inhibits angiogenesis by degradation of Mcl-1 through ERK inactivation. Sun HL, Tsai AC, Pan SL, Ding Q, Yamaguchi H, Lin CN, Hung MC, Teng CM. Clin Cancer Res; 2009 Aug 01; 15(15):4904-14. PubMed ID: 19622586 [Abstract] [Full Text] [Related]
46. Fumagillin inhibits colorectal cancer growth and metastasis in mice: in vivo and in vitro study of anti-angiogenesis. Hou L, Mori D, Takase Y, Meihua P, Kai K, Tokunaga O. Pathol Int; 2009 Jul 01; 59(7):448-61. PubMed ID: 19563408 [Abstract] [Full Text] [Related]
47. Fascaplysin exert anti-tumor effects through apoptotic and anti-angiogenesis pathways in sarcoma mice model. Yan X, Chen H, Lu X, Wang F, Xu W, Jin H, Zhu P. Eur J Pharm Sci; 2011 Jul 17; 43(4):251-9. PubMed ID: 21569843 [Abstract] [Full Text] [Related]
48. Different effects of angiogenesis inhibitors IFN-alpha and TIMP-1 on lymphangiogenesis. Shao XJ, Lu WQ, Liu C. Lymphology; 2008 Jun 17; 41(2):64-74. PubMed ID: 18720913 [Abstract] [Full Text] [Related]
49. Honokiol regulates ovarian cancer cell malignant behavior through YAP/TAZ pathway modulation. Liu F, Zhang Y, Xia X, Han J, Cao L. J Obstet Gynaecol Res; 2024 Jun 17; 50(6):1010-1019. PubMed ID: 38576101 [Abstract] [Full Text] [Related]
50. Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin. Hu H, Zhang XX, Wang YY, Chen SZ. Acta Pharmacol Sin; 2005 Sep 17; 26(9):1063-8. PubMed ID: 16115372 [Abstract] [Full Text] [Related]
51. Honokiol, a multifunctional tumor cell death inducer. Tian W, Xu D, Deng YC. Pharmazie; 2012 Oct 17; 67(10):811-6. PubMed ID: 23136712 [Abstract] [Full Text] [Related]
52. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma. Wang Z, Zhou J, Fan J, Qiu SJ, Yu Y, Huang XW, Tang ZY. Clin Cancer Res; 2008 Aug 15; 14(16):5124-30. PubMed ID: 18698030 [Abstract] [Full Text] [Related]
53. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, Der CJ, Battle T, Frank DA, Ye K, Murad E, Dubiel W, Soff G, Arbiser JL. J Biol Chem; 2003 Sep 12; 278(37):35501-7. PubMed ID: 12816951 [Abstract] [Full Text] [Related]
54. Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity. Hu J, Chen LJ, Liu L, Chen X, Chen PL, Yang G, Hou WL, Tang MH, Zhang F, Wang XH, Zhao X, Wei YQ. Exp Mol Med; 2008 Dec 31; 40(6):617-28. PubMed ID: 19116447 [Abstract] [Full Text] [Related]
55. Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities. Dings RP, Chen X, Hellebrekers DM, van Eijk LI, Zhang Y, Hoye TR, Griffioen AW, Mayo KH. J Natl Cancer Inst; 2006 Jul 05; 98(13):932-6. PubMed ID: 16818857 [Abstract] [Full Text] [Related]
56. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice]. Sun W, Jiang Z, Xiang TX, Tao XH, Huang AL, Wang PL. Zhonghua Yi Xue Za Zhi; 2009 Mar 31; 89(12):841-5. PubMed ID: 19595126 [Abstract] [Full Text] [Related]
57. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells. Lee DH, Szczepanski MJ, Lee YJ. J Cell Biochem; 2009 Apr 15; 106(6):1113-22. PubMed ID: 19229860 [Abstract] [Full Text] [Related]
58. Antineoplastic Effects of Honokiol on Melanoma. Guillermo-Lagae R, Santha S, Thomas M, Zoelle E, Stevens J, Kaushik RS, Dwivedi C. Biomed Res Int; 2017 Apr 15; 2017():5496398. PubMed ID: 28194418 [Abstract] [Full Text] [Related]
59. Honokiol induces caspase-independent paraptosis via reactive oxygen species production that is accompanied by apoptosis in leukemia cells. Wang Y, Zhu X, Yang Z, Zhao X. Biochem Biophys Res Commun; 2013 Jan 18; 430(3):876-82. PubMed ID: 23262230 [Abstract] [Full Text] [Related]
60. Calpain/SHP-1 interaction by honokiol dampening peritoneal dissemination of gastric cancer in nu/nu mice. Liu SH, Wang KB, Lan KH, Lee WJ, Pan HC, Wu SM, Peng YC, Chen YC, Shen CC, Cheng HC, Liao KK, Sheu ML. PLoS One; 2012 Jan 18; 7(8):e43711. PubMed ID: 22937084 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]